Global Beta-Nicotinamide Mononucleotide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Beta-Nicotinamide Mononucleotide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Beta-Nicotinamide Mononucleotide market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Beta-Nicotinamide Mononucleotide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Beta-Nicotinamide Mononucleotide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Beta-Nicotinamide Mononucleotide market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Beta-Nicotinamide Mononucleotide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Beta-Nicotinamide Mononucleotide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical and Maac10 Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Beta-Nicotinamide Mononucleotide market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Beta-Nicotinamide Mononucleotide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Beta-Nicotinamide Mononucleotide, with price, sales, revenue and global market share of Beta-Nicotinamide Mononucleotide from 2018 to 2023.
Chapter 3, the Beta-Nicotinamide Mononucleotide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beta-Nicotinamide Mononucleotide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Beta-Nicotinamide Mononucleotide market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Beta-Nicotinamide Mononucleotide.
Chapter 14 and 15, to describe Beta-Nicotinamide Mononucleotide sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Beta-Nicotinamide Mononucleotide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Beta-Nicotinamide Mononucleotide market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Beta-Nicotinamide Mononucleotide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Beta-Nicotinamide Mononucleotide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Beta-Nicotinamide Mononucleotide market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Beta-Nicotinamide Mononucleotide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Beta-Nicotinamide Mononucleotide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical and Maac10 Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Beta-Nicotinamide Mononucleotide market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Above 98%
- Below 98%
- Health Care Products
- Cosmetics
- Others
- GeneHarbor
- Herbalmax
- Genex Formulas
- Shinkowa Pharmaceutical
- Maac10 Formulas
- EffePharm
- Bontac
- CELFULL
- Kingdomway
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Beta-Nicotinamide Mononucleotide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Beta-Nicotinamide Mononucleotide, with price, sales, revenue and global market share of Beta-Nicotinamide Mononucleotide from 2018 to 2023.
Chapter 3, the Beta-Nicotinamide Mononucleotide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beta-Nicotinamide Mononucleotide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Beta-Nicotinamide Mononucleotide market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Beta-Nicotinamide Mononucleotide.
Chapter 14 and 15, to describe Beta-Nicotinamide Mononucleotide sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Beta-Nicotinamide Mononucleotide
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Beta-Nicotinamide Mononucleotide Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Above 98%
1.3.3 Below 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Beta-Nicotinamide Mononucleotide Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Health Care Products
1.4.3 Cosmetics
1.4.4 Others
1.5 Global Beta-Nicotinamide Mononucleotide Market Size & Forecast
1.5.1 Global Beta-Nicotinamide Mononucleotide Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Beta-Nicotinamide Mononucleotide Sales Quantity (2018-2029)
1.5.3 Global Beta-Nicotinamide Mononucleotide Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide Product and Services
2.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GeneHarbor Recent Developments/Updates
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax Beta-Nicotinamide Mononucleotide Product and Services
2.2.4 Herbalmax Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Herbalmax Recent Developments/Updates
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide Product and Services
2.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genex Formulas Recent Developments/Updates
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product and Services
2.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide Product and Services
2.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Maac10 Formulas Recent Developments/Updates
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm Beta-Nicotinamide Mononucleotide Product and Services
2.6.4 EffePharm Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 EffePharm Recent Developments/Updates
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac Beta-Nicotinamide Mononucleotide Product and Services
2.7.4 Bontac Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bontac Recent Developments/Updates
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL Beta-Nicotinamide Mononucleotide Product and Services
2.8.4 CELFULL Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CELFULL Recent Developments/Updates
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway Beta-Nicotinamide Mononucleotide Product and Services
2.9.4 Kingdomway Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kingdomway Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BETA-NICOTINAMIDE MONONUCLEOTIDE BY MANUFACTURER
3.1 Global Beta-Nicotinamide Mononucleotide Sales Quantity by Manufacturer (2018-2023)
3.2 Global Beta-Nicotinamide Mononucleotide Revenue by Manufacturer (2018-2023)
3.3 Global Beta-Nicotinamide Mononucleotide Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Beta-Nicotinamide Mononucleotide by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Beta-Nicotinamide Mononucleotide Manufacturer Market Share in 2022
3.4.2 Top 6 Beta-Nicotinamide Mononucleotide Manufacturer Market Share in 2022
3.5 Beta-Nicotinamide Mononucleotide Market: Overall Company Footprint Analysis
3.5.1 Beta-Nicotinamide Mononucleotide Market: Region Footprint
3.5.2 Beta-Nicotinamide Mononucleotide Market: Company Product Type Footprint
3.5.3 Beta-Nicotinamide Mononucleotide Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Beta-Nicotinamide Mononucleotide Market Size by Region
4.1.1 Global Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2029)
4.1.2 Global Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2029)
4.1.3 Global Beta-Nicotinamide Mononucleotide Average Price by Region (2018-2029)
4.2 North America Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
4.3 Europe Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
4.4 Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
4.5 South America Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
4.6 Middle East and Africa Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
5.2 Global Beta-Nicotinamide Mononucleotide Consumption Value by Type (2018-2029)
5.3 Global Beta-Nicotinamide Mononucleotide Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
6.2 Global Beta-Nicotinamide Mononucleotide Consumption Value by Application (2018-2029)
6.3 Global Beta-Nicotinamide Mononucleotide Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
7.2 North America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
7.3 North America Beta-Nicotinamide Mononucleotide Market Size by Country
7.3.1 North America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2029)
7.3.2 North America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
8.2 Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
8.3 Europe Beta-Nicotinamide Mononucleotide Market Size by Country
8.3.1 Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2029)
8.3.2 Europe Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide Market Size by Region
9.3.1 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
10.2 South America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
10.3 South America Beta-Nicotinamide Mononucleotide Market Size by Country
10.3.1 South America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2029)
10.3.2 South America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Beta-Nicotinamide Mononucleotide Market Size by Country
11.3.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Beta-Nicotinamide Mononucleotide Market Drivers
12.2 Beta-Nicotinamide Mononucleotide Market Restraints
12.3 Beta-Nicotinamide Mononucleotide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Beta-Nicotinamide Mononucleotide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Beta-Nicotinamide Mononucleotide
13.3 Beta-Nicotinamide Mononucleotide Production Process
13.4 Beta-Nicotinamide Mononucleotide Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Beta-Nicotinamide Mononucleotide Typical Distributors
14.3 Beta-Nicotinamide Mononucleotide Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Beta-Nicotinamide Mononucleotide
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Beta-Nicotinamide Mononucleotide Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Above 98%
1.3.3 Below 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Beta-Nicotinamide Mononucleotide Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Health Care Products
1.4.3 Cosmetics
1.4.4 Others
1.5 Global Beta-Nicotinamide Mononucleotide Market Size & Forecast
1.5.1 Global Beta-Nicotinamide Mononucleotide Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Beta-Nicotinamide Mononucleotide Sales Quantity (2018-2029)
1.5.3 Global Beta-Nicotinamide Mononucleotide Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide Product and Services
2.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GeneHarbor Recent Developments/Updates
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax Beta-Nicotinamide Mononucleotide Product and Services
2.2.4 Herbalmax Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Herbalmax Recent Developments/Updates
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide Product and Services
2.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genex Formulas Recent Developments/Updates
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product and Services
2.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide Product and Services
2.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Maac10 Formulas Recent Developments/Updates
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm Beta-Nicotinamide Mononucleotide Product and Services
2.6.4 EffePharm Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 EffePharm Recent Developments/Updates
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac Beta-Nicotinamide Mononucleotide Product and Services
2.7.4 Bontac Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bontac Recent Developments/Updates
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL Beta-Nicotinamide Mononucleotide Product and Services
2.8.4 CELFULL Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CELFULL Recent Developments/Updates
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway Beta-Nicotinamide Mononucleotide Product and Services
2.9.4 Kingdomway Beta-Nicotinamide Mononucleotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kingdomway Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BETA-NICOTINAMIDE MONONUCLEOTIDE BY MANUFACTURER
3.1 Global Beta-Nicotinamide Mononucleotide Sales Quantity by Manufacturer (2018-2023)
3.2 Global Beta-Nicotinamide Mononucleotide Revenue by Manufacturer (2018-2023)
3.3 Global Beta-Nicotinamide Mononucleotide Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Beta-Nicotinamide Mononucleotide by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Beta-Nicotinamide Mononucleotide Manufacturer Market Share in 2022
3.4.2 Top 6 Beta-Nicotinamide Mononucleotide Manufacturer Market Share in 2022
3.5 Beta-Nicotinamide Mononucleotide Market: Overall Company Footprint Analysis
3.5.1 Beta-Nicotinamide Mononucleotide Market: Region Footprint
3.5.2 Beta-Nicotinamide Mononucleotide Market: Company Product Type Footprint
3.5.3 Beta-Nicotinamide Mononucleotide Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Beta-Nicotinamide Mononucleotide Market Size by Region
4.1.1 Global Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2029)
4.1.2 Global Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2029)
4.1.3 Global Beta-Nicotinamide Mononucleotide Average Price by Region (2018-2029)
4.2 North America Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
4.3 Europe Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
4.4 Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
4.5 South America Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
4.6 Middle East and Africa Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
5.2 Global Beta-Nicotinamide Mononucleotide Consumption Value by Type (2018-2029)
5.3 Global Beta-Nicotinamide Mononucleotide Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
6.2 Global Beta-Nicotinamide Mononucleotide Consumption Value by Application (2018-2029)
6.3 Global Beta-Nicotinamide Mononucleotide Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
7.2 North America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
7.3 North America Beta-Nicotinamide Mononucleotide Market Size by Country
7.3.1 North America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2029)
7.3.2 North America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
8.2 Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
8.3 Europe Beta-Nicotinamide Mononucleotide Market Size by Country
8.3.1 Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2029)
8.3.2 Europe Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide Market Size by Region
9.3.1 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
10.2 South America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
10.3 South America Beta-Nicotinamide Mononucleotide Market Size by Country
10.3.1 South America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2029)
10.3.2 South America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Beta-Nicotinamide Mononucleotide Market Size by Country
11.3.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Beta-Nicotinamide Mononucleotide Market Drivers
12.2 Beta-Nicotinamide Mononucleotide Market Restraints
12.3 Beta-Nicotinamide Mononucleotide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Beta-Nicotinamide Mononucleotide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Beta-Nicotinamide Mononucleotide
13.3 Beta-Nicotinamide Mononucleotide Production Process
13.4 Beta-Nicotinamide Mononucleotide Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Beta-Nicotinamide Mononucleotide Typical Distributors
14.3 Beta-Nicotinamide Mononucleotide Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Beta-Nicotinamide Mononucleotide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Beta-Nicotinamide Mononucleotide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor Beta-Nicotinamide Mononucleotide Product and Services
Table 6. GeneHarbor Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GeneHarbor Recent Developments/Updates
Table 8. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 9. Herbalmax Major Business
Table 10. Herbalmax Beta-Nicotinamide Mononucleotide Product and Services
Table 11. Herbalmax Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Herbalmax Recent Developments/Updates
Table 13. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 14. Genex Formulas Major Business
Table 15. Genex Formulas Beta-Nicotinamide Mononucleotide Product and Services
Table 16. Genex Formulas Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Genex Formulas Recent Developments/Updates
Table 18. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Shinkowa Pharmaceutical Major Business
Table 20. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product and Services
Table 21. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shinkowa Pharmaceutical Recent Developments/Updates
Table 23. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 24. Maac10 Formulas Major Business
Table 25. Maac10 Formulas Beta-Nicotinamide Mononucleotide Product and Services
Table 26. Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Maac10 Formulas Recent Developments/Updates
Table 28. EffePharm Basic Information, Manufacturing Base and Competitors
Table 29. EffePharm Major Business
Table 30. EffePharm Beta-Nicotinamide Mononucleotide Product and Services
Table 31. EffePharm Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. EffePharm Recent Developments/Updates
Table 33. Bontac Basic Information, Manufacturing Base and Competitors
Table 34. Bontac Major Business
Table 35. Bontac Beta-Nicotinamide Mononucleotide Product and Services
Table 36. Bontac Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bontac Recent Developments/Updates
Table 38. CELFULL Basic Information, Manufacturing Base and Competitors
Table 39. CELFULL Major Business
Table 40. CELFULL Beta-Nicotinamide Mononucleotide Product and Services
Table 41. CELFULL Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CELFULL Recent Developments/Updates
Table 43. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 44. Kingdomway Major Business
Table 45. Kingdomway Beta-Nicotinamide Mononucleotide Product and Services
Table 46. Kingdomway Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kingdomway Recent Developments/Updates
Table 48. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 49. Global Beta-Nicotinamide Mononucleotide Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Beta-Nicotinamide Mononucleotide Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 51. Market Position of Manufacturers in Beta-Nicotinamide Mononucleotide, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Beta-Nicotinamide Mononucleotide Production Site of Key Manufacturer
Table 53. Beta-Nicotinamide Mononucleotide Market: Company Product Type Footprint
Table 54. Beta-Nicotinamide Mononucleotide Market: Company Product Application Footprint
Table 55. Beta-Nicotinamide Mononucleotide New Market Entrants and Barriers to Market Entry
Table 56. Beta-Nicotinamide Mononucleotide Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2023) & (Tons)
Table 58. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2024-2029) & (Tons)
Table 59. Global Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Beta-Nicotinamide Mononucleotide Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Beta-Nicotinamide Mononucleotide Average Price by Region (2018-2023) & (US$/Ton)
Table 62. Global Beta-Nicotinamide Mononucleotide Average Price by Region (2024-2029) & (US$/Ton)
Table 63. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 64. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 65. Global Beta-Nicotinamide Mononucleotide Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Beta-Nicotinamide Mononucleotide Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Beta-Nicotinamide Mononucleotide Average Price by Type (2018-2023) & (US$/Ton)
Table 68. Global Beta-Nicotinamide Mononucleotide Average Price by Type (2024-2029) & (US$/Ton)
Table 69. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 70. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 71. Global Beta-Nicotinamide Mononucleotide Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Beta-Nicotinamide Mononucleotide Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Beta-Nicotinamide Mononucleotide Average Price by Application (2018-2023) & (US$/Ton)
Table 74. Global Beta-Nicotinamide Mononucleotide Average Price by Application (2024-2029) & (US$/Ton)
Table 75. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 76. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 77. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 78. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 79. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2023) & (Tons)
Table 80. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2024-2029) & (Tons)
Table 81. North America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 84. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 85. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 86. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 87. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2023) & (Tons)
Table 88. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2024-2029) & (Tons)
Table 89. Europe Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Beta-Nicotinamide Mononucleotide Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 92. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 93. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 94. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 95. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2023) & (Tons)
Table 96. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2024-2029) & (Tons)
Table 97. Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 100. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 101. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 102. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 103. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2023) & (Tons)
Table 104. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2024-2029) & (Tons)
Table 105. South America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 108. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 109. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 110. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 111. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2023) & (Tons)
Table 112. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2024-2029) & (Tons)
Table 113. Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Beta-Nicotinamide Mononucleotide Raw Material
Table 116. Key Manufacturers of Beta-Nicotinamide Mononucleotide Raw Materials
Table 117. Beta-Nicotinamide Mononucleotide Typical Distributors
Table 118. Beta-Nicotinamide Mononucleotide Typical Customers
Table 1. Global Beta-Nicotinamide Mononucleotide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Beta-Nicotinamide Mononucleotide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor Beta-Nicotinamide Mononucleotide Product and Services
Table 6. GeneHarbor Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GeneHarbor Recent Developments/Updates
Table 8. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 9. Herbalmax Major Business
Table 10. Herbalmax Beta-Nicotinamide Mononucleotide Product and Services
Table 11. Herbalmax Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Herbalmax Recent Developments/Updates
Table 13. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 14. Genex Formulas Major Business
Table 15. Genex Formulas Beta-Nicotinamide Mononucleotide Product and Services
Table 16. Genex Formulas Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Genex Formulas Recent Developments/Updates
Table 18. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Shinkowa Pharmaceutical Major Business
Table 20. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product and Services
Table 21. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shinkowa Pharmaceutical Recent Developments/Updates
Table 23. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 24. Maac10 Formulas Major Business
Table 25. Maac10 Formulas Beta-Nicotinamide Mononucleotide Product and Services
Table 26. Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Maac10 Formulas Recent Developments/Updates
Table 28. EffePharm Basic Information, Manufacturing Base and Competitors
Table 29. EffePharm Major Business
Table 30. EffePharm Beta-Nicotinamide Mononucleotide Product and Services
Table 31. EffePharm Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. EffePharm Recent Developments/Updates
Table 33. Bontac Basic Information, Manufacturing Base and Competitors
Table 34. Bontac Major Business
Table 35. Bontac Beta-Nicotinamide Mononucleotide Product and Services
Table 36. Bontac Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bontac Recent Developments/Updates
Table 38. CELFULL Basic Information, Manufacturing Base and Competitors
Table 39. CELFULL Major Business
Table 40. CELFULL Beta-Nicotinamide Mononucleotide Product and Services
Table 41. CELFULL Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CELFULL Recent Developments/Updates
Table 43. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 44. Kingdomway Major Business
Table 45. Kingdomway Beta-Nicotinamide Mononucleotide Product and Services
Table 46. Kingdomway Beta-Nicotinamide Mononucleotide Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kingdomway Recent Developments/Updates
Table 48. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 49. Global Beta-Nicotinamide Mononucleotide Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Beta-Nicotinamide Mononucleotide Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 51. Market Position of Manufacturers in Beta-Nicotinamide Mononucleotide, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Beta-Nicotinamide Mononucleotide Production Site of Key Manufacturer
Table 53. Beta-Nicotinamide Mononucleotide Market: Company Product Type Footprint
Table 54. Beta-Nicotinamide Mononucleotide Market: Company Product Application Footprint
Table 55. Beta-Nicotinamide Mononucleotide New Market Entrants and Barriers to Market Entry
Table 56. Beta-Nicotinamide Mononucleotide Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2023) & (Tons)
Table 58. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2024-2029) & (Tons)
Table 59. Global Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Beta-Nicotinamide Mononucleotide Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Beta-Nicotinamide Mononucleotide Average Price by Region (2018-2023) & (US$/Ton)
Table 62. Global Beta-Nicotinamide Mononucleotide Average Price by Region (2024-2029) & (US$/Ton)
Table 63. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 64. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 65. Global Beta-Nicotinamide Mononucleotide Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Beta-Nicotinamide Mononucleotide Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Beta-Nicotinamide Mononucleotide Average Price by Type (2018-2023) & (US$/Ton)
Table 68. Global Beta-Nicotinamide Mononucleotide Average Price by Type (2024-2029) & (US$/Ton)
Table 69. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 70. Global Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 71. Global Beta-Nicotinamide Mononucleotide Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Beta-Nicotinamide Mononucleotide Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Beta-Nicotinamide Mononucleotide Average Price by Application (2018-2023) & (US$/Ton)
Table 74. Global Beta-Nicotinamide Mononucleotide Average Price by Application (2024-2029) & (US$/Ton)
Table 75. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 76. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 77. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 78. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 79. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2023) & (Tons)
Table 80. North America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2024-2029) & (Tons)
Table 81. North America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 84. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 85. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 86. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 87. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2023) & (Tons)
Table 88. Europe Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2024-2029) & (Tons)
Table 89. Europe Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Beta-Nicotinamide Mononucleotide Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 92. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 93. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 94. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 95. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2023) & (Tons)
Table 96. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2024-2029) & (Tons)
Table 97. Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 100. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 101. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 102. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 103. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2018-2023) & (Tons)
Table 104. South America Beta-Nicotinamide Mononucleotide Sales Quantity by Country (2024-2029) & (Tons)
Table 105. South America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Beta-Nicotinamide Mononucleotide Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2018-2023) & (Tons)
Table 108. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Type (2024-2029) & (Tons)
Table 109. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2018-2023) & (Tons)
Table 110. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Application (2024-2029) & (Tons)
Table 111. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2018-2023) & (Tons)
Table 112. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity by Region (2024-2029) & (Tons)
Table 113. Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Beta-Nicotinamide Mononucleotide Raw Material
Table 116. Key Manufacturers of Beta-Nicotinamide Mononucleotide Raw Materials
Table 117. Beta-Nicotinamide Mononucleotide Typical Distributors
Table 118. Beta-Nicotinamide Mononucleotide Typical Customers
LIST OF FIGURES
Figure 1. Beta-Nicotinamide Mononucleotide Picture
Figure 2. Global Beta-Nicotinamide Mononucleotide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Type in 2022
Figure 4. Above 98% Examples
Figure 5. Below 98% Examples
Figure 6. Global Beta-Nicotinamide Mononucleotide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Application in 2022
Figure 8. Health Care Products Examples
Figure 9. Cosmetics Examples
Figure 10. Others Examples
Figure 11. Global Beta-Nicotinamide Mononucleotide Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Beta-Nicotinamide Mononucleotide Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Beta-Nicotinamide Mononucleotide Sales Quantity (2018-2029) & (Tons)
Figure 14. Global Beta-Nicotinamide Mononucleotide Average Price (2018-2029) & (US$/Ton)
Figure 15. Global Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Beta-Nicotinamide Mononucleotide by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Beta-Nicotinamide Mononucleotide Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Beta-Nicotinamide Mononucleotide Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Beta-Nicotinamide Mononucleotide Average Price by Type (2018-2029) & (US$/Ton)
Figure 30. Global Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Beta-Nicotinamide Mononucleotide Average Price by Application (2018-2029) & (US$/Ton)
Figure 33. North America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Region (2018-2029)
Figure 53. China Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Beta-Nicotinamide Mononucleotide Market Drivers
Figure 74. Beta-Nicotinamide Mononucleotide Market Restraints
Figure 75. Beta-Nicotinamide Mononucleotide Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide in 2022
Figure 78. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide
Figure 79. Beta-Nicotinamide Mononucleotide Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Beta-Nicotinamide Mononucleotide Picture
Figure 2. Global Beta-Nicotinamide Mononucleotide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Type in 2022
Figure 4. Above 98% Examples
Figure 5. Below 98% Examples
Figure 6. Global Beta-Nicotinamide Mononucleotide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Application in 2022
Figure 8. Health Care Products Examples
Figure 9. Cosmetics Examples
Figure 10. Others Examples
Figure 11. Global Beta-Nicotinamide Mononucleotide Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Beta-Nicotinamide Mononucleotide Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Beta-Nicotinamide Mononucleotide Sales Quantity (2018-2029) & (Tons)
Figure 14. Global Beta-Nicotinamide Mononucleotide Average Price (2018-2029) & (US$/Ton)
Figure 15. Global Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Beta-Nicotinamide Mononucleotide by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Beta-Nicotinamide Mononucleotide Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Beta-Nicotinamide Mononucleotide Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Beta-Nicotinamide Mononucleotide Average Price by Type (2018-2029) & (US$/Ton)
Figure 30. Global Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Beta-Nicotinamide Mononucleotide Average Price by Application (2018-2029) & (US$/Ton)
Figure 33. North America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Region (2018-2029)
Figure 53. China Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Beta-Nicotinamide Mononucleotide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Beta-Nicotinamide Mononucleotide Market Drivers
Figure 74. Beta-Nicotinamide Mononucleotide Market Restraints
Figure 75. Beta-Nicotinamide Mononucleotide Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide in 2022
Figure 78. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide
Figure 79. Beta-Nicotinamide Mononucleotide Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
